Entinostat- Experimental Drug May Help Reprogram Tumor Cells To Respond To Hormone Therapy In Triple Negative Breast Cancer Patients

Triple Negative Breast Cancer cells

“We hope that Entinostat will make the tumor cells more sensitive to the drug anastrozole, causing the tumor to shrink or, at the very least, stop growing,” Dr. Chumsri says.
http://www.umm.edu/news/releases/triple-negative-breast-cancer.htm
(Click to link)





"The study will help researchers determine if an experimental drug, entinostat, can reprogram tumor cells to express a protein molecule called an estrogen receptor to make them sensitive to hormone therapy."